累计签到:138 天
连续签到:1 天
[LV.7]狂热爱粉
请教您,Ilaria Marrocco et al, L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab, Cell Reports Medicine (2023).,,
这个后续,又有什么消息? 很早爱必妥之前也试验非小了(是个比较成熟的药??),还没有纳入非小适应症? |
|
|
|